These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10071704)

  • 1. The use of antioxidants in retarding atherosclerosis: fact or fiction?
    Futterman LG; Lemberg L
    Am J Crit Care; 1999 Mar; 8(2):130-3. PubMed ID: 10071704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins and oxidative stress during atherogenesis.
    Norata GD; Pirillo A; Catapano AL
    J Cardiovasc Risk; 2003 Jun; 10(3):181-9. PubMed ID: 12775950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress, antioxidant vitamins, and atherosclerosis. From basic research to clinical practice.
    Antoniades C; Tousoulis D; Tentolouris C; Toutouzas P; Stefanadis C
    Herz; 2003 Nov; 28(7):628-38. PubMed ID: 14689123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of modification of lipoproteins and of the immune system in early atherogenesis.
    Mol MJ; Demacker PN; Stalenhoef AF
    Neth J Med; 1993 Aug; 43(1-2):83-90. PubMed ID: 8232700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atheroprotective effects of antioxidants through inhibition of mitogen-activated protein kinases.
    Kyaw M; Yoshizumi M; Tsuchiya K; Izawa Y; Kanematsu Y; Tamaki T
    Acta Pharmacol Sin; 2004 Aug; 25(8):977-85. PubMed ID: 15301727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antioxidant vitamins--significance for preventing cardiovascular diseases. Part 1. Oxidized low-density lipoproteins and atherosclerosis; antioxidant dietary supplementation--vitamin E].
    Andreeva-Gateva P
    Vutr Boles; 2000; 32(3):11-8. PubMed ID: 11688317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of free radicals and antioxidant on the vascular wall].
    Ginter E
    Vnitr Lek; 2000 Jun; 46(6):354-9. PubMed ID: 15645843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin E for the treatment of cardiovascular disease: is there a future?
    Violi F; Cangemi R; Sabatino G; Pignatelli P
    Ann N Y Acad Sci; 2004 Dec; 1031():292-304. PubMed ID: 15753155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there a role for supplemented antioxidants in the prevention of atherosclerosis?
    Katsiki N; Manes C
    Clin Nutr; 2009 Feb; 28(1):3-9. PubMed ID: 19042058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin E does not regress hypercholesterolemic atherosclerosis.
    Prasad K
    J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):231-41. PubMed ID: 19498106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antioxidants and healthy aging.
    Hasnis E; Reznick AZ
    Isr Med Assoc J; 2003 May; 5(5):368-70. PubMed ID: 12811959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antioxidants suppress plasma levels of lectinlike oxidized low-density lipoprotein receptor-ligands and reduce atherosclerosis in watanabe heritable hyperlipidemic rabbits.
    Oka K; Yasuhara M; Suzumura K; Tanaka K; Sawamura T
    J Cardiovasc Pharmacol; 2006 Oct; 48(4):177-83. PubMed ID: 17086097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antioxidant vitamins - importance for cardiopulmonary prophylaxis. Part II. Antioxidant food supplies - vitamin C and beta-carotene; current experience in antioxidant vitamin usage].
    Andreeva-Gateva P
    Vutr Boles; 2000; 32(4):5-12. PubMed ID: 11688331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N,N'-diacetyl-L-cystine (DiNAC), the disulphide dimer of N-acetylcysteine, inhibits atherosclerosis in WHHL rabbits: evidence for immunomodulatory agents as a new approach to prevent atherosclerosis.
    Wågberg M; Jansson AH; Westerlund C; Ostlund-Lindqvist AM; Särnstrand B; Bergstrand H; Pettersson K
    J Pharmacol Exp Ther; 2001 Oct; 299(1):76-82. PubMed ID: 11561065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of oxidants and antioxidants in atherosclerosis: results of in vitro and in vivo investigations.
    Siekmeier R; Steffen C; März W
    J Cardiovasc Pharmacol Ther; 2007 Dec; 12(4):265-82. PubMed ID: 18172221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of green tea-derived catechin on developing versus established atherosclerosis in apolipoprotein E-null mice.
    Chyu KY; Babbidge SM; Zhao X; Dandillaya R; Rietveld AG; Yano J; Dimayuga P; Cercek B; Shah PK
    Circulation; 2004 May; 109(20):2448-53. PubMed ID: 15136500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of vitamins A, C, and E and their relationship to cardiovascular disease.
    Brown DJ; Goodman J
    Clin Excell Nurse Pract; 1998 Jan; 2(1):10-22. PubMed ID: 12675072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antioxidant supplementation decreases lipid peroxidation biomarker F(2)-isoprostanes in plasma of smokers.
    Dietrich M; Block G; Hudes M; Morrow JD; Norkus EP; Traber MG; Cross CE; Packer L
    Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):7-13. PubMed ID: 11815395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of vitamin C and vitamin E on oxidative DNA damage: results from a randomized controlled trial.
    Huang HY; Helzlsouer KJ; Appel LJ
    Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):647-52. PubMed ID: 10919732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.